Resonate Blends, Inc. (KOAN) stock
Close on Oct 19, 2026Market cap $75.01KP/E –Yield –
Resonate Blends, Inc. grew revenue 2100.9% to $2.23M over the twelve months to Mar 31, 2025. Free cash flow was -$1.07M. At the latest close the market valued the company at $75.01K.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Mar 31, 2025
Valuation
- Market cap
- $75.01K
- P/E ratio
- –
- Price to sales
- 0.03
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -1422.28%
Fundamentals
- Revenue
- $2.23M
- Net income
- -$2.00M
- EPS, diluted
- -$0.02
- Free cash flow
- -$1.07M
- Book value per share
- -$0.03
- Diluted shares
- 150M
Trading
- Previous close
- $0.00
- Open
- $0.00
- Day's range
- $0.00 – $0.00
- Volume
- 27,790,550
- Average volume (20 days)
- 5,592,704
Market cap history
Month-end market cap since 2014, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | KOAN | S&P 500 | Difference | KOAN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +66.7% | +0.6% | +66.0 pts | ||
| 3 months | 0.0% | +3.4% | −3.4 pts | ||
| Year to date | -83.7% | +13.3% | −97.0 pts | ||
| 1 year | -96.2% | +16.6% | −112.8 pts | ||
| 3 years | -99.4% | +86.4% | −185.8 pts | -82.1% | +23.1% |
| 5 years | -99.9% | +81.9% | −181.7 pts | -73.7% | +12.7% |
| 10 years | -100.0% | +318.9% | −418.8 pts | -57.7% | +15.4% |
Fourteen years at a glance
Fiscal years 2011 to 2024 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Resonate Blends filed with the SEC as exhibits to Form 8-K or 6-K
About Resonate Blends
Services-Prepackaged Software
Resonate Blends, Inc. operates in the regenerative medicine sector, focusing on nutritionally designed products that aim to support human health without pharmaceuticals. The company centers its development and marketing efforts on natural stem cell mobilizing formulations designed to help individuals release adult stem cells from bone marrow. Additionally, it offers a dual-acting natural dietary aid intended to assist with appetite control through physiological signaling. These products target both general consumer and professional healthcare markets, with ongoing research exploring secretagogues to enhance natural growth hormone production and other bioactive formulations.
Company profile, executives and historyResonate Blends stock: common questions
What is Resonate Blends's stock price?
KOAN closed at $0.00 on Oct 19, 2026, up 16.28% on the day.
What is Resonate Blends's market cap?
Resonate Blends was worth $75.01K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is KOAN's P/E ratio?
Resonate Blends lost money over the twelve months to Mar 31, 2025 (diluted EPS -$0.02), so it has no meaningful P/E ratio.
How much revenue does Resonate Blends make?
Resonate Blends reported revenue of $2.23M for the twelve months to Mar 31, 2025, up 2100.9% from a year earlier.
Does Resonate Blends pay a dividend?
No. Resonate Blends has not paid a cash dividend over the last twelve months.
How has KOAN stock performed over the past year?
Including dividends, KOAN returned -96.2% over the past year, against +16.6% for the S&P 500.
Who are Resonate Blends's competitors?
Companies most similar to Resonate Blends by business, industry and size include UMEW, BHIC, GXAI, VPRB, VIIQ.
See a number that looks wrong?